The findings of real-world evidence studies sometimes contradicts the results of randomized clinical trials. This raises the question of how to reconcile the two.
The growing volume of biomedical literature is both a help and a hindrance to HEOR. New text-mining tools, however, are radically improving the efficiency of literature-based information retrieval
The Sentinel Initiative means that the FDA is becoming proactive in monitoring safety. Pharma can be more proactive too.
You Don’t Know What You Don’t know is a common phrase in Pharma, however, letting data give you a full picture is one way to know what you don’t know
Safe Harbor prohibits much of the communication between commercial operations and Medical Affairs; publication planners may not be able to easily access the R&D work that has come before; regional affiliates may be presenting posters at meetings independent of headquarters. Can your organization see the full picture?